Company: CMND
Filing Date: 2025-09-17
Form Type: 6-K
Source: 0001213900-25-088566
Chunk: 2

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-17
Form: 6-K
Chunk 2
---
 not obligated
to utilize any of the remaining Subscription Amount available under the SPAs, and there are no minimum commitments or minimum use penalties.
The SPAs do not impose any restrictions on the Company’s operating activities. The SPAs contain customary representations, warranties
and representations by the Company. The descriptions of the SPAs and Form of Note set forth above are qualified in their entirety by reference
to the full text of those documents, which are attached hereto as Exhibits 10.1 and 4.1, respectively.

<div align='center'>1</div>

The securities described above
(the “Securities”) were and will be issued and sold in a private placement exempt from the registration requirements of the
Securities Act of 1933, as amended (the “Securities Act”), and have not been registered under the Securities Act, or applicable
state securities laws. Accordingly, the Securities may not be sold in the United States except pursuant to an effective registration statement
or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities law. The Company
has agreed to file a registration statement (the “Registration Statement”) with the SEC to register the resale of the Common
Shares issuable upon conversion of the Notes.

This Report of Foreign Private
Issuer on Form 6-K shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein,
nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such state or jurisdiction.

This Form 6-K is incorporated
by reference into the Registrant’s Registration Statements on Form F-3 (File Nos.333-275991, 333-270859, 333-273293)
and Form S-8 (File No. 333-283695),
filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent
not superseded by documents or reports subsequently filed or furnished.

Cautionary Note Regarding Forward-Looking Statements

This Report of Foreign Private
Issuer on Form 6-K contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act
and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,”
“believes,” “seeks,” “estimates” and similar expressions or variations